{"id":"methylene-blue-infusion","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Hypotension"},{"rate":"5-10%","effect":"Tachycardia"},{"rate":"5-10%","effect":"Headache"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Methylene blue acts as a potent inhibitor of monoamine oxidase A (MAO-A) and monoamine oxidase B (MAO-B), which are enzymes responsible for the breakdown of monoamines such as dopamine, serotonin, and norepinephrine.","oneSentence":"A monoamine oxidase inhibitor","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T02:00:58.349Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of methemoglobinemia"},{"name":"Diagnostic aid for certain conditions"}]},"trialDetails":[{"nctId":"NCT07264543","phase":"PHASE2, PHASE3","title":"Early Methylene Blue in the Microhemodynamics of Septic Patients","status":"RECRUITING","sponsor":"Centro de Estudos e Pesquisa em Emergencias Medicas e Terapia Intensiva","startDate":"2026-01-09","conditions":"Septic Shock, Hypoperfusion","enrollment":50},{"nctId":"NCT06900140","phase":"PHASE3","title":"Adjunctive Methylene Blue in Septic Shock","status":"COMPLETED","sponsor":"Dr. Shannon M. Fernando","startDate":"2025-06-02","conditions":"Septic Shock","enrollment":50},{"nctId":"NCT07448129","phase":"NA","title":"Clinical Trial to Evaluate the Efficacy and Safety of SUBMO® as a Submucosal Injection Agent in Endoscopic Resection of Superficial Gastrointestinal Lesions.","status":"NOT_YET_RECRUITING","sponsor":"i+Med S.Coop.","startDate":"2026-03","conditions":"Colorectal Polyps","enrollment":300},{"nctId":"NCT06532240","phase":"PHASE3","title":"Methylene Blue for the Treatment of Septic Shock","status":"COMPLETED","sponsor":"Northern Jiangsu People's Hospital","startDate":"2024-08-05","conditions":"Septic Shock","enrollment":88},{"nctId":"NCT07150819","phase":"NA","title":"A Multidisciplinary Perioperative Pain Management","status":"WITHDRAWN","sponsor":"China-Japan Friendship Hospital","startDate":"2022-07-01","conditions":"Anorectal Surgery, Pain Management","enrollment":""},{"nctId":"NCT07179003","phase":"PHASE2","title":"A Phase 2 Study of Methylene Blue Photodynamic Therapy for Treatment of Breast Abscesses","status":"NOT_YET_RECRUITING","sponsor":"University of Rochester","startDate":"2026-04","conditions":"Breast Abscess","enrollment":50},{"nctId":"NCT07169487","phase":"PHASE1","title":"Adjunctive Methylene Blue for Immunotherapy-related CRS and ICANS: Phase I Study","status":"RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2025-06-28","conditions":"Cytokine Release Syndrome, ICANS","enrollment":18},{"nctId":"NCT06567691","phase":"NA","title":"Endoscopic Gastroenterostomy Versus Surgical Gastrojejunostomy","status":"ENROLLING_BY_INVITATION","sponsor":"Vanderbilt University Medical Center","startDate":"2025-08-01","conditions":"Malignant Gastric Outlet Obstruction","enrollment":34},{"nctId":"NCT05830630","phase":"NA","title":"Perineural Methylene Blue Infusion in Lower Limb Amputation Surgery","status":"RECRUITING","sponsor":"Tanta University","startDate":"2023-05-01","conditions":"Perineural, Methylene Blue, Lower Limb Amputation","enrollment":72},{"nctId":"NCT04529265","phase":"NA","title":"Methylene Blue and Postoperative Neurocognitive Disorders","status":"COMPLETED","sponsor":"Fudan University","startDate":"2021-05-01","conditions":"Postoperative Delirium","enrollment":314},{"nctId":"NCT05092165","phase":"PHASE2","title":"Methylene Blue for the Prevention of Hypotension During Hemodialysis","status":"RECRUITING","sponsor":"Federal University of São Paulo","startDate":"2021-10-21","conditions":"Acute Kidney Injury, Shock","enrollment":260},{"nctId":"NCT06481410","phase":"NA","title":"Efficacy and Safety of Methylene Blue in the Treatment of Severe Septic Shock","status":"RECRUITING","sponsor":"First Affiliated Hospital of Zhejiang University","startDate":"2024-06-22","conditions":"Septic Shock, Methylene Blue, Sepsis","enrollment":488},{"nctId":"NCT06005558","phase":"PHASE2, PHASE3","title":"Low Dose Versus High Dose Methylene Blue in Septic Patients","status":"COMPLETED","sponsor":"National Cancer Institute, Egypt","startDate":"2023-08-01","conditions":"Septic Shock","enrollment":90},{"nctId":"NCT04054999","phase":"PHASE4","title":"Methylene Blue vs Cyanokit for Intraoperative Vasoplegic Syndrome in Liver Transplant Patients","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2019-11-30","conditions":"Vasoplegic Syndrome, Liver Transplant; Complications","enrollment":19},{"nctId":"NCT06306001","phase":"PHASE2, PHASE3","title":"Intravenous Methylene Blue for Treating Refractory Neonatal Septic Shock","status":"NOT_YET_RECRUITING","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2024-03-15","conditions":"Neonatal Sepsis, Shock, Septic","enrollment":130},{"nctId":"NCT05812521","phase":"NA","title":"Thoracic Paravertebral Block With Methylene Blue Visual Confirmation for Postoperative Pain After VATS Lobectomy","status":"COMPLETED","sponsor":"University of Campania Luigi Vanvitelli","startDate":"2020-01-15","conditions":"Post Operative Pain, Thoracic Cancer","enrollment":120},{"nctId":"NCT04446871","phase":"PHASE2, PHASE3","title":"Methylene Blue in Early Septic Shock","status":"COMPLETED","sponsor":"Hospital Civil de Guadalajara","startDate":"2017-03-17","conditions":"Septic Shock","enrollment":91},{"nctId":"NCT04089072","phase":"PHASE2","title":"Methylene Blue as a Third-line Vasopressor in Septic Shock","status":"UNKNOWN","sponsor":"Carilion Clinic","startDate":"2019-12-01","conditions":"Septic Shock","enrollment":250},{"nctId":"NCT04621123","phase":"PHASE2","title":"Plasma for Early Treatment in Non-hospitalised Mild or Moderate COVID-19 Patients","status":"COMPLETED","sponsor":"Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia","startDate":"2020-11-10","conditions":"SARS-CoV-2 Infection, Safety and Efficacy","enrollment":384},{"nctId":"NCT04970602","phase":"NA","title":"The Effect of Early Use of Methylene Blue on Hemodynamics in Septic Shock","status":"UNKNOWN","sponsor":"Xiangya Hospital of Central South University","startDate":"2021-06-20","conditions":"Septic Shock","enrollment":106},{"nctId":"NCT04547127","phase":"PHASE2","title":"A Study to Evaluate Safety and Efficacy of Convalescent Methylene Blue Treated (MBT) Plasma From Donors Recovered From Coronavirus Disease 2019 (COVID-19)","status":"COMPLETED","sponsor":"Instituto Grifols, S.A.","startDate":"2020-04-29","conditions":"COVID-19","enrollment":200},{"nctId":"NCT04341844","phase":"NA","title":"Intraoperative Infusion of Methylene Blue for Prevention of Postoperative Delirium and Cognitive Dysfunction in Elderly Patients Undergoing Major Elective Noncardiac Surgery","status":"COMPLETED","sponsor":"Fudan University","startDate":"2019-01-14","conditions":"Postoperative Delirium, Postoperative Cognitive Dysfunction","enrollment":248},{"nctId":"NCT04295993","phase":"PHASE3","title":"Methylene Blue and Microcirculation in Septic Shock","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2020-03-10","conditions":"Septic Shock","enrollment":32},{"nctId":"NCT04250389","phase":"","title":"Microcirculatory Effects of Methylene Blue","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2017-01-01","conditions":"Acute Circulatory Failure","enrollment":25},{"nctId":"NCT04110418","phase":"PHASE2","title":"Methylene Blue Versus Vasopressin Analogue for Treatment of Septic Shock in Preterm Neonate","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2019-02-19","conditions":"Neonatal Sepsis, Refractory Shock","enrollment":36},{"nctId":"NCT01522443","phase":"PHASE3","title":"Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer","status":"TERMINATED","sponsor":"Exelixis","startDate":"2012-03","conditions":"Prostate Cancer, Castration Resistant Prostate Cancer, Pain","enrollment":119},{"nctId":"NCT02910765","phase":"PHASE4","title":"Methylene Blue and Ozone in Early Sepsis","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2016-10","conditions":"Sepsis","enrollment":40},{"nctId":"NCT02755311","phase":"PHASE3","title":"Liver Resection Versus Transarterial Chemoembolization for the Treatment of Intermediate-stage Hepatocellular Carcinoma","status":"UNKNOWN","sponsor":"Sun Yat-sen University","startDate":"2014-03","conditions":"Hepatocellular Carcinoma","enrollment":198},{"nctId":"NCT01797978","phase":"PHASE3","title":"Methylene Blue in Severe Sepsis and Septic Shock","status":"UNKNOWN","sponsor":"Seoul National University Hospital","startDate":"2013-02","conditions":"Severe Sepsis, Septic Shock","enrollment":354},{"nctId":"NCT00159510","phase":"PHASE1","title":"Studies of Acute Lung Injury (ALI) and Acute Respiratory Distress Syndrome","status":"TERMINATED","sponsor":"Northern State Medical University","startDate":"2004-04","conditions":"Sepsis","enrollment":28},{"nctId":"NCT02303886","phase":"NA","title":"Methylene Blue Intravenously and Chronic Neuropathic Pain","status":"COMPLETED","sponsor":"Uppsala University","startDate":"2009-03","conditions":"Neuropathic Pain","enrollment":10},{"nctId":"NCT00486174","phase":"NA","title":"Methylene Blue in Sepsis: A Randomized Controlled Trial","status":"WITHDRAWN","sponsor":"Queen's University","startDate":"2007-06","conditions":"Sepsis","enrollment":""}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"AKATHISIA"},{"count":1,"reaction":"APHASIA"},{"count":1,"reaction":"BLOOD PHOSPHORUS INCREASED"},{"count":1,"reaction":"DELAYED RECOVERY FROM ANAESTHESIA"},{"count":1,"reaction":"DRUG TOXICITY"},{"count":1,"reaction":"DYSKINESIA"},{"count":1,"reaction":"GLASGOW COMA SCALE ABNORMAL"},{"count":1,"reaction":"INFLAMMATION"},{"count":1,"reaction":"MEDICATION ERROR"},{"count":1,"reaction":"MENTAL STATUS CHANGES"}],"_approvalHistory":[],"publicationCount":69,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Methylene blue","Phenothiazines"],"phase":"phase_2","status":"active","brandName":"Methylene blue infusion","genericName":"Methylene blue infusion","companyName":"Centro de Estudos e Pesquisa em Emergencias Medicas e Terapia Intensiva","companyId":"centro-de-estudos-e-pesquisa-em-emergencias-medicas-e-terapia-intensiva","modality":"Small molecule","firstApprovalDate":"","aiSummary":"A monoamine oxidase inhibitor Used for Treatment of methemoglobinemia, Diagnostic aid for certain conditions.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":2,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}